Skip to main content
logo
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.4532
-0.0451 (-9.05%)
At close: Jul 2, 2026, 4:00 PM EDT
0.4540
+0.0008 (0.18%)
After-hours: Jul 2, 2026, 7:55 PM EDT

Vivos Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-25.12-21.23-11.14-13.58-23.85-20.29
Depreciation & Amortization
1.591.310.580.620.670.73
Stock-Based Compensation
0.50.660.761.112.42.66
Other Adjustments
0.75-0.04-2.95-0.521.13
Change in Receivables
-0.27-0.22-0.230.260.750.23
Changes in Accounts Payable
0.540.52-1.050.730.490.14
Changes in Accrued Expenses
3.813.62-0.040.42-0.941.12
Changes in Unearned Revenue
-0.24-0.51-1.43-0.610.64-0.54
Changes in Other Operating Activities
0.460.59-0.192.060.78-0.92
Operating Cash Flow
-17.48-15.26-12.69-11.95-19.59-15.74
Capital Expenditures
-2.24-2.34-0.57-0.8-0.92-2.4
Purchases of Intangible Assets
----0.05--
Payments for Business Acquisitions
-2.57-5.19----0.23
Other Investing Activities
-----0.01
Investing Cash Flow
-7.42-7.53-0.57-0.85-0.92-2.61
Long-Term Debt Issued
12.0710.67----
Long-Term Debt Repaid
-0.41-----0.03
Net Long-Term Debt Issued (Repaid)
11.6710.67----0.03
Issuance of Common Stock
7.448.7519.2412-27.93
Net Common Stock Issued (Repurchased)
7.448.7519.2412-27.93
Repurchase of Preferred Stock
------1.5
Net Preferred Stock Issued (Repurchased)
------1.5
Other Financing Activities
-1.32-0.87-1.36-1.08--2.24
Financing Cash Flow
24.6718.5617.8810.92-24.17
Net Cash Flow
-0.23-4.234.62-1.88-20.515.82
Free Cash Flow
-19.71-17.6-13.26-12.75-20.51-18.13
FCF Margin
-100.75%-100.92%-88.21%-92.38%-128.00%-107.38%
Free Cash Flow Per Share
-1.67-1.71-1.29-0.01-0.02-0.02
Levered Free Cash Flow
-9.54-7.32-13.84-11.16-23.14-22.18
Unlevered Free Cash Flow
-18.69-16.71-13.87-14.87-24.32-22.25
SEC Filings: 10-K · 10-Q